NeoDynamics AB (publ) invests in biopsy instrument for more effective sampling of suspected skin cancer
NeoDynamics AB (publ) starts a joint venture, for the development of a new biopsy instrument for more effective tissue sampling of suspected skin cancer.NeoDynamics invests in a newly formed company, which will produce an improved punch biopsy instrument for more efficient sampling of suspected skin cancer. The project has already received a grant from Swedish Innovation Agency Vinnova (MedTech4Health) and concept development and evaluation have been conducted together with Karolinska Hospital during 2018. The purpose of the investment is to continue the project towards a finished product